Completed
Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
NCT04098068
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +10 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Ohio State University Columbus, Ohio, United States